Primary invasive oral aspergillosis: an updated literature review.
Fuqua
Thomas H
TH
Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, AL 35249-7331, USA.
Sittitavornwong
Somsak
S
Knoll
Michael
M
Said-Al-Naief
Nasser
N
D000212:Acyclovir / Q000627:therapeutic use; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications* / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D009059:Mouth Diseases / Q000150:complications* / Q000188:drug therapy*; D010254:Paranasal Sinus Diseases / Q000150:complications / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D000998:Antiviral Agents; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D065819:Voriconazole; D000212:Acyclovir